Back
Verisk Analytics Vs. Axsome Therapeutics Industry Stock Comparison
Buy
68
VRSK
Verisk Analytics
Last Price:
$294.52
Seasonality Move:
5.01%
Sell
47
AXSM
Axsome Therapeutics
Last Price:
$118.50
Seasonality Move:
19.74%
Buy
68
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $294.58. The Score for VRSK is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $118.53. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $294.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRSK is experiencing slight selling pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $118.53The current trend is moderately bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
VRSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -141384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (287.72 - 297.24) | Buy |
| Bollinger Bands (100): | (278.18 - 293.46) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 44.34 | Sell |
| Chaikin Money Flow: | -342463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.72 - 129.02) | Sell |
| Bollinger Bands (100): | (88.92 - 120.8) | Buy |
VRSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289.91 | Buy |
| 20-day SMA: | 292.32 | Buy |
| 50-day SMA: | 289.56 | Buy |
| 200-day SMA: | 277.69 | Buy |
| 8-day EMA: | 291.6 | Buy |
| 20-day EMA: | 291.28 | Buy |
| 50-day EMA: | 289.34 | Buy |
| 200-day EMA: | 275.69 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.49 | Sell |
| 20-day SMA: | 123.64 | Sell |
| 50-day SMA: | 117.5 | Buy |
| 200-day SMA: | 95.28 | Buy |
| 8-day EMA: | 122.09 | Sell |
| 20-day EMA: | 122.82 | Sell |
| 50-day EMA: | 117.2 | Buy |
| 200-day EMA: | 98.97 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.25 per share, an increase this year of $1.54 per share, and an increase next year of $5.14 per share.
Verisk Analytics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||